ELCV vs SBIO
Eventide High Dividend ETF vs ALPS Medical Breakthroughs ETF
Quick Verdict
ELCV has a lower expense ratio. SBIO delivered stronger 1-year returns. SBIO offers more diversification with 105 holdings.
Side-by-Side Comparison
| Metric | ELCV | SBIO | Winner |
|---|---|---|---|
| Expense Ratio | 0.49% | 0.50% | |
| AUM | $251M | $202M | |
| Dividend Yield | 2.06% | 4.05% | |
| Holdings | 47 | 87 | |
| YTD Return | +21.26% | +35.11% | |
| 1Y Return | +27.07% | +101.30% | |
| 3Y Return (annualized) | - | +32.81% | |
| 5Y Return (annualized) | - | +9.88% | |
| Volatility (annualized) | 13.9% | 29.6% | |
| Max Drawdown | -18.4% | -63.1% | |
| Fund Family | Eventide | ALPS Advisors | |
| Category | Equity | Equity | |
| Inception | Sep 30, 2024 | Dec 30, 2014 |
ELCV vs SBIO Performance
Eventide High Dividend ETF (ELCV) is a ETF from Eventide and ALPS Medical Breakthroughs ETF (SBIO) is a ETF from ALPS Advisors. Over the past year ELCV returned +27.07% while SBIO returned +101.30%. Year to date, ELCV is up 21.26% versus a gain of 35.11% for SBIO.
Risk: Volatility and Drawdowns
SBIO has been the more volatile fund, with annualized monthly volatility of 29.6% compared with 13.9% for ELCV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -18.4% for ELCV and -63.1% for SBIO. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.40. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
ELCV charges 0.49% per year while SBIO charges 0.50%. On a $10,000 position that is $49 vs $50 annually, a gap of $1 per year that compounds over a long holding period. On income, ELCV currently yields 2.06% against 4.05% for SBIO.
Holdings Overlap
ELCV and SBIO share 0 holdings out of 151 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, ELCV or SBIO?
ELCV has an expense ratio of 0.49% while SBIO charges 0.50%. ELCV is the cheaper option. On a $10,000 investment, that is $1 per year of difference.
Which performed better, ELCV or SBIO?
Over the past year ELCV returned +27.07% vs +101.30% for SBIO, so SBIO leads on 1-year performance. Over the longest common window we track (2 years), ELCV annualized +16.47% vs +9.81% for SBIO. Past performance does not guarantee future results.
Which is riskier, ELCV or SBIO?
SBIO has been the more volatile fund at 29.6% annualized versus 13.9% for ELCV. Worst drawdown: ELCV -18.4% vs SBIO -63.1%.
Should I hold both ELCV and SBIO?
ELCV and SBIO have a monthly-return correlation of 0.40, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between ELCV and SBIO?
ELCV and SBIO share 0 common holdings with a 0.0% weight overlap. Combined, they hold 151 unique securities.
Which pays a higher dividend, ELCV or SBIO?
ELCV yields 2.06% while SBIO yields 4.05%, so SBIO currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.